Table 2 Antimicrobial susceptibility pattern of CNS isolates
Antibiotics | Total (n = 214) | S. epidermidis (n = 123) | S. saprophyticus (n = 40) | S. hemolyticus (n = 24) | S. hominis (n = 15) | S. capitis (n = 12) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
R | S | R | S | R | S | R | S | R | S | R | S | |
CNS | ||||||||||||
 Penicillin | 196 (91.6%) | 18 (8.4%) | 111 (90.2%) | 12 (9.8%) | 39 (97.5%) | 1 (2.5%) | 23 (95.8%) | 1 (4.2%) | 12 (80%) | 3 (20%) | 11 (91.7%) | 1 (8.3%) |
 Ciprofloxacin | 76 (35.5%) | 138 (64.5%) | 39 (31.7%) | 84 (68.35) | 7 (17.5%) | 33 (82.5%) | 17 (70.8%) | 7 (29.2%) | 5 (33.3%) | 10 (66.75) | 8 (66.7%) | 4 (33.3%) |
 Tetracycline | 27 (12.6%) | 187 (87.4%) | 11 (8.9%) | 112 (91.1%) | 8 (20%) | 32 (80%) | 7 (29.2%) | 17 (70.8%) | 1 (6.7%) | 14 (93.3%) | - | 12 (100%) |
 Clindamycin | 63 (29.4%) | 151 (70.6%) | 30 (24.4%) | 93 (75.6%) | 13 (32.5%) | 27 (67.5%) | 9 (37.5%) | 15 (62.5%) | 5 (33.3%) | 10 (66.7%) | 6 (50%) | 6 (50%) |
 Chloramphenicol | 19 (8.9%) | 195 (91.1%) | 9 (7.3%) | 114 (92.7%) | 5 (12.5%) | 35 (87.5%) | 1 (4.2%) | 23 (95.8%) | 2 (13.3%) | 13 (86.7%) | 2 (16.7%) | 10 (83.3%) |
 Cefoxitin | 143 (6.5%) | 71 (33.2%) | 73 (59.3%) | 50 (40.7%) | 29 (72.5%) | 11 (27.5%) | 21 (87.5%) | 3 (12.5%) | 10 (66.7%) | 5 (33.3%) | 10 (83.3%) | 2 (16.7%) |
 Erythromycin | 155 (72.4%) | 59 (27.6%) | 80 (65%) | 43 (35%) | 34 (85%) | 6 (15%) | 21 (87.5%) | 3 (12.5%) | 10 (66.7%) | 5 (33.3%) | 10 (83.3%) | 2 (16.7%) |
 Cotrimoxazole | 80 (37.4%) | 134 (62.6%) | 46 (37.4%) | 77 (62.6%) | 14 (35%) | 26 (65%) | 10 (41.7%) | 14 (58.3%) | 6 (40%) | 9 (60%) | 4 (33.3%) | 8 (66.7%) |
 Gentamicin | 45 (21%) | 169 (79%) | 17 (13.8%) | 106 (86.2%) | 8 (20%) | 32 (80%) | 14 (58.3%) | 10 (41.7%) | – | 15 (100%) | 6 (50%) | 6 (50%) |